Anti-Venom Market

Anti-Venom Market by Type (Monovalent, Polyvalent), Reptile type (Snake, Spider, Scorpion), and Mode of Action (Cytotoxic, Neurotoxic, Cardiotoxic) - Analysis & Global Forecast to 2021

Report Code: UC 1680 Sep, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Anti-Venom Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Anti-Venom Market

Request For Special Pricing

Anti-venom (or antivenin or antivenene) is a biological product used in the treatment of venomous bites or stings. Treatment with specific anti-venoms is considered the only cure for the venomous bite.  Various reptile bites that require the anti-venom vaccine include snakes, scorpions, and spiders, among others. Snake anti-venoms are the widely used anti-venoms. Snakebite has recently been declared a global public health emergency. As per the WHO estimates, 5 Million people are bitten each year with up to 2.5 Million envenomings.  In addition, at least 100 000 people die as a result of snake bites each year, and around three times as many amputations and other permanent disabilities are caused by snakebites annually.

The anti-venom market in developed countries is declining due to the decreased mortality from snakebites in these regions. However, snakebite is a recognized medical emergency in developing countries where majority of people are people living in rural communities, with children and agricultural workers most at risk. Estimates show that snakebites occur most in South and Southeast Asia, in Sub-Saharan Africa, and Latin America. The declining anti-venom availability and rising mortality due to snake bites in the developing countries is pushing the demand for anti-venoms in areas like Africa, Asia, and Latin America. However, some of the factors that are restraining the market include:

  • Inadequate investment by governments and non-government organisations;
  • High manufacturing costs and inefficient production processes;
  • Inconsistent quality standards; and
  • Inappropriate clinical application.

Various measures required to provide stimulus to the market include:

  • Financial stimulus to identify and develop dependable sources of high-grade anti-venoms,
  • Support current and emerging manufacturers, and
  • Capitalise on existing unutilized production capacity.
  • Investing to ensure a consistent and sustainable marketplace for efficacious anti-venom products

Target Audience for the Report

Pharmaceutical Companies

Research Institutes

Scope of the Report:

This research report categorizes the global anti-venom market into the following segments:

Global Anti-Venom Market, by Type

  • Monovalent
  • Polyvalent

Global Anti-Venom Market, by Reptile

  • Snake
  • Common Cobra
  • Common Krait
  • Russell Viper
  • Others
  • Scorpion
  • Spider
  • Others (If Any)

Global Anti-Venom Market, by Mode of Action

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others (If Any)

Global Anti-Venom Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
           2.2.3 Market Size Estimation Methodology
           2.2.4 Research Design
           2.2.5 Market Data Validation and Triangulation
           2.2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraints
           5.3.3 Opportunities

6 Global Antivenom Vaccine Market, By Type
    6.1 Introduction
    6.2 Monovalent Antivenom
    6.3 Polyvalent Antivenom

7 Global Antivenom Vaccine Market, By Reptile
    7.1 Introduction
    7.2 Snake
           7.2.1 Common Cobra
           7.2.2 Common Krait
           7.2.3 Russellís Viper
           7.2.4 Others (If Any)
    7.3 Scorpion
    7.4  Spider
    7.5  Others (If Any)

8 Global Antivenom Vaccine Market, By Mode of Action
    8.1 Introduction
    8.2 Cytotoxic
    8.3 Neurotoxic
    8.4 Haemotoxic
    8.5 Cardiotoxic
    8.6 Myotoxic
    8.7 Others (If Any)

9 Competitive Landscape
    9.1 Overview
    9.2 Competitive Situations and Trends
           9.2.1 Agreements, Collaborations, Mergers, and Partnerships
           9.2.2 New Product Launches
           9.2.3 Acquisitions
           9.2.4 Expansion
           9.2.5 Others (If Any)

10 Company Profiles
     10.1 Introduction
     10.2 Medtoxin Venom Laboratories
             10.2.1 Business Overview
             10.2.2 Financial Overview
             10.2.3 Service Offerings
             10.2.4 Recent Developments
     10.3 Institute of Immunology
     10.4 Alomone Labs, Ltd.
     10.5 Sigma Aldrich
     10.6 Wyeth Pharmaceuticals Limited
     10.7 Protherics PLC
     10.8 Bharat Serums and Vaccines Limited
     10.9 Butantan Institute
     10.10 Haffkine Bio-Pharmaceutical Corporation Limited
     10.11 Micropaharm Limited

Note:  1. Pointers 10.2.1 to 10.2.4 will be replicated for top 10 companies

Note:
1. All the above markets will be provided for the years 2014, 2015, 2016, and 2021
2. Revenue for companies might not be captured for companies whose financial data is not available in public domain
3. The above scope is tentative and is subject to change as the research progresses 


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
7 6 6 0 9  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1680
Available for Pre-Book
Choose License Type
Prebook Now
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Anti-Venom Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home